Patents by Inventor Norihito Nakata

Norihito Nakata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230094773
    Abstract: The RI-labeled anti-MUC5AC humanized antibody of the present invention is a conjugate of a chelating agent chelated with a radionuclide and an antibody (the radionuclide is a metal nuclide that emits ? particle or positron, and the antibody is a humanized antibody specifically binding to MUC5AC), and is superior in specificity for MUC5AC and accumulation in tumor. Therefore, it is extremely useful for the treatment and/or diagnosis of diseases in which MUC5AC is overexpressed, particularly cancer.
    Type: Application
    Filed: May 26, 2022
    Publication date: March 30, 2023
    Applicants: NIHON MEDI-PHYSICS CO., LTD., SUMITOMO PHARMA CO., LTD.
    Inventors: Norihito Nakata, Nobuya Kobashi, Yoshinari Shoyama, Mitsuhiro Matono, Yasushi Ochiai, Takayuki Murakami
  • Patent number: 11369701
    Abstract: The RI-labeled anti-MUC5AC humanized antibody of the present invention is a conjugate of a chelating agent chelated with a radionuclide and an antibody (the radionuclide is a metal nuclide that emits ? particle or positron, and the antibody is a humanized antibody specifically binding to MUC5AC), and is superior in specificity for MUC5AC and accumulation in tumor. Therefore, it is extremely useful for the treatment and/or diagnosis of diseases in which MUC5AC is overexpressed, particularly cancer.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: June 28, 2022
    Assignees: NIHON MEDI-PHYSICS CO., LTD., SUMITOMO PHARMA CO., LTD.
    Inventors: Norihito Nakata, Nobuya Kobashi, Yoshinari Shoyama, Mitsuhiro Matono, Yasushi Ochiai, Takayuki Murakami
  • Publication number: 20210338852
    Abstract: The RI-labeled anti-MUC5AC humanized antibody of the present invention is a conjugate of a chelating agent chelated with a radionuclide and an antibody (the radionuclide is a metal nuclide that emits ? particle or positron, and the antibody is a humanized antibody specifically binding to MUC5AC), and is superior in specificity for MUC5AC and accumulation in tumor. Therefore, it is extremely useful for the treatment and/or diagnosis of diseases in which MUC5AC is overexpressed, particularly cancer.
    Type: Application
    Filed: July 2, 2021
    Publication date: November 4, 2021
    Applicants: NIHON MEDI-PHYSICS CO., LTD., SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Norihito Nakata, Nobuya Kobashi, Yoshinari Shoyama, Mitsuhiro Matono, Yasushi Ochiai, Takayuki Murakami
  • Publication number: 20210322582
    Abstract: The present invention provides a radiolabeled compound represented by the following formula (1), which is a radioactive imidazothiadiazole derivative compound having an affinity for CA-IX, or a salt thereof. wherein n is an integer of 1 to 4, and L represents a radionuclide or a mono- to tetravalent group containing a radionuclide.
    Type: Application
    Filed: August 30, 2019
    Publication date: October 21, 2021
    Applicants: Nihon Medi-Physics Co., Ltd., Kyoto University
    Inventors: Masato KIRIU, Norihito NAKATA, Tsutomu ABE, Masahiro ONO
  • Publication number: 20200181196
    Abstract: The present invention relates to an IgG-binding peptide comprising a ligand capable of binding to a radioactive metal nuclide, an IgG-binding peptide labeled with a radioactive metal nuclide, a conjugate of the IgG-binding peptide and IgG, and a radionuclide imaging agent or a diagnostic agent for cancer comprising the IgG-binding peptide or the conjugate, etc.
    Type: Application
    Filed: June 12, 2017
    Publication date: June 11, 2020
    Applicant: Kagoshima University
    Inventors: Yuji ITO, Yoshinari SHOYAMA, Akio HAYASHI, Norihito NAKATA
  • Patent number: 10037042
    Abstract: A valve control system for a steam turbine that decrease in effective power as well as secure control stability in the event of an electric power system accident is provided. A valve control system for a steam turbine includes an accident detection unit 44 which detects an occurrence of an electric power system accident, a first selection unit 45 which selects, from a plurality of control valves 13 (13a˜13d) which adjust a volume of steam flowing into a steam turbine, control valves 13 to be rapidly closed according to a scale of the accident detected, and a normal control circuit 11 which continues normal pressure or speed control by the control valves 13 which are not selected.
    Type: Grant
    Filed: February 18, 2014
    Date of Patent: July 31, 2018
    Assignee: KABUSHIKI KAISHA TOSHIBA
    Inventors: Norihito Nakata, Toshio Aoki, Masaaki Matsumoto
  • Publication number: 20180193493
    Abstract: Provided is a method for imaging a renal lesion comprising the steps of administrating a nitroimidazole-based compound to a living body and obtaining an image of the renal lesion by detecting radiation non-invasively from the outside of the living body wherein the renal imaging agent comprises a defined nitroimidazole-based compound or a salt thereof. The step of obtaining the image of the renal lesion can include using positron emission tomography.
    Type: Application
    Filed: March 8, 2018
    Publication date: July 12, 2018
    Applicant: NIHON MEDI-PHYSICS CO., LTD.
    Inventor: Norihito NAKATA
  • Publication number: 20170281803
    Abstract: The present invention provides a renal imaging agent comprising a nitroimidazole-type compound or a salt thereof. The renal imaging agent according to the present invention can be used in positron emission tomography.
    Type: Application
    Filed: September 7, 2015
    Publication date: October 5, 2017
    Applicant: NIHON MEDI-PHYSICS CO., LTD.
    Inventor: Norihito NAKATA
  • Publication number: 20150378369
    Abstract: A valve control system for a steam turbine that decrease in effective power as well as secure control stability in the event of an electric power system accident is provided. A valve control system for a steam turbine includes an accident detection unit 44 which detects an occurrence of an electric power system accident, a first selection unit 45 which selects, from a plurality of control valves 13 (13a˜13d) which adjust a volume of steam flowing into a steam turbine, control valves 13 to be rapidly closed according to a scale of the accident detected, and a normal control circuit 11 which continues normal pressure or speed control by the control valves 13 which are not selected.
    Type: Application
    Filed: February 18, 2014
    Publication date: December 31, 2015
    Applicant: KABUSHIKI KAISHA TOSHIBA
    Inventors: Norihito NAKATA, Toshio AOKI, Masaaki MATSUMOTO
  • Patent number: 9107964
    Abstract: The present invention is a compound represented by the following formula (1) or a salt thereof. In the formula (1), R1 denotes a hydrogen atom, a methyl group, or a hydroxymethyl group, and n is an integer of 1 or 2.
    Type: Grant
    Filed: September 18, 2012
    Date of Patent: August 18, 2015
    Assignees: NIHON MEDI-PHYSICS CO., LTD., NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventors: Norihito Nakata, Yuki Okumura, Masato Kiriu, Eriko Nagata, Hiroki Matsumoto, Yuji Kuge, Songji Zhao, Ken-Ichi Nishijima
  • Publication number: 20140364620
    Abstract: The present invention is a compound represented by the following formula (1) or a salt thereof. In the formula (1), R1 denotes a hydrogen atom, a methyl group, or a hydroxymethyl group, and n is an integer of 1 or 2.
    Type: Application
    Filed: September 18, 2012
    Publication date: December 11, 2014
    Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventors: Norihito Nakata, Yuki Okumura, Masato Kiriu, Eriko Nagata, Hiroki Matsumoto, Yuji Kuge, Songji Zhao, Ken-Ichi Nishijima